Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale

In 2024, medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale trade exhibited significant decline, with global flows reaching $12,984,952 and a three-year compound annual growth rate of -43.0% (five-year: -36.1%). The all-time peak of $216,589,985 was recorded in 2013; the current level is 94% below that high-water mark.

Over the 30-year observation window (1995–2024), 41% of years recorded positive growth, indicating significant cyclicality with frequent contractions. Trend momentum is decelerating (-21.1% acceleration).

The World Trade Flows Characterization classifies medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale as "One-way trade" in the medium price range price segment, providing additional context for market positioning and competitive dynamics.

The supply side is concentrated (Herfindahl-Hirschman Index 0.438). The three largest exporters — Denmark ($57.8M), United States ($14.4M), and Germany ($8.5M) — collectively dominate supply flows. The leading exporter has grown at -22.9% over the last three years.

On the demand side, importer concentration is concentrated (HHI 0.267). The three largest import markets are Denmark ($5.8M), France ($3.2M), and United Kingdom ($630.2K). The largest importing market sources from 10 different supplying countries.

Estimated substitution elasticity: -22.15. Buyers are highly price-sensitive and can switch between suppliers relatively easily.

The dominant trade corridor is Denmark → Iran at $41.3M, representing 99.5% of the importer's total demand.

The volatility score for medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale is 58 out of 100, classified as medium. Trade flows are moderately variable, typical for goods with seasonal or cyclical demand patterns.

For market entrants, contracting demand signals caution before committing resources. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.